Has Ronald Childs, MD received payments from drug or device companies?

Yes. Drug and device makers reported $447,394 in general payments to Ronald Childs, MD across 157 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ronald Childs, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ronald Childs, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ronald Childs, MD

Orthopaedic Surgery · Mc Lean, VANPI 1154343986

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $388,280 of the $447,394 with a category attached, or 86.8%. Stryker accounts for 83.4% of it on its own, with 20 other manufacturers making up the rest. Among orthopaedic surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$447,394in general payments, 2019–2025

Across 157 payments — averaging $2849.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$373K
VB Spine LLC$51K
Kuros Biosciences USA, Inc$10K
Alphatec Spine, Inc$7K
Medtronic$2K
Arthrex$1K
plus $3K from 15 others

What the payments were for

Royalty or licence$388,28087%
Consulting fees$40,1139%
Travel & lodging$13,3883%
Food & beverage$5,6141%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	74	$373,349
VB Spine LLC	7	$51,356
Kuros Biosciences USA, Inc	12	$9,571
Alphatec Spine, Inc	6	$6,674
Medtronic	20	$2,237
Arthrex	9	$1,453
Arteriocyte Medical Systems, Inc.	3	$623
Orthofix Medical, Inc.	3	$609
Supreme Orthopedic Systems, LLC	6	$592
Globus Medical	3	$184
Degen Medical, Inc.	1	$174
Life Spine, Inc.	1	$134
Augmedics Inc.	2	$121
Axis Spine Technologies Inc.	1	$101
Endo Pharmaceuticals Inc.	2	$48
GS Solutions, Inc.	1	$39
Seaspine Orthopedics Corporation	1	$37
Johnson & Johnson(2 entities)	2	$34
Biocomposites Inc	1	$29
Surgalign Spine Technologies, Inc.	1	$20
Providence Medical Technology, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CASCADIA INTERBODY SYSTEM$306,407
CASCADIA$78,122
ALLOGRAFT$16,088
ES2$9,500
MagnetOs$9,153
Other - Miscellaneous$6,621
EVEREST MI$5,000
ALEUTIAN TLIF MI$5,000
LATERAL ACCESS SPINAL SYSTEM$5,000
EVEREST XT$5,000
LITE PLATE SYSTEM$4,225
ALEUTIAN INTERBODY SYSTEMS$4,225
RAVINE LATERAL ACCESS SYSTEM$3,988
GENERAL K2M PRODUCT DISCUSSION$3,000
CD HORIZON SPINAL SYSTEM$1,736
N/A$1,466
7D Surgical System$500
TRITANIUM$365
SPINE INSTRUMENTS ENDOSCOPIC INSTRUMENT SETS$357
EVEREST SPINAL SYSTEM$315

How this compares

$447,394 in reported general payments places this provider in the 95th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia →

Medicare billing

Part B allowed, 2024

$309,728

Medicare patients

524

Services billed

1,481

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	33	$232
Cyclobenzaprine Hcl	13	$128

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Mc Lean

Dale YoungNorth Chesterfield$10.9M
James DowdVirginia Beach$6.1M
Mark de BloisNorth Chesterfield$4M
Cato LaurencinCharlottesville$3.5M
Randall PeytonSterling$2.9M
William MihalkoCharlottesville$2M
David MillerNorth Chesterfield$1.7M
Keith LawhornFairfax$1.6M
Joseph GonduskyVirginia Beach$1.2M
Joshua HerzogNorth Chesterfield$1M

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →